Latest Insider Transactions at Maximus, Inc. (MMS)
This section provides a real-time view of insider transactions for Maximus, Inc. (MMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MAXIMUS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MAXIMUS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 17
2024
|
Bruce Caswell CEO & President |
BUY
Open market or private purchase
|
Direct |
3,500
+1.25%
|
$245,000
$70.64 P/Share
|
Dec 12
2024
|
Raymond B Ruddy |
BUY
Open market or private purchase
|
Direct |
3,490
+3.01%
|
$247,790
$71.46 P/Share
|
Dec 12
2024
|
David Mutryn Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
4,000
-29.39%
|
-
|
Dec 12
2024
|
John J Haley |
BUY
Open market or private purchase
|
Direct |
3,490
+2.98%
|
$247,790
$71.76 P/Share
|
Dec 03
2024
|
Michelle F. Link Chief of Human Resources |
SELL
Open market or private sale
|
Direct |
2,208
-25.17%
|
$161,184
$73.83 P/Share
|
Dec 02
2024
|
Michelle F. Link Chief of Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-17.14%
|
$134,310
$74.16 P/Share
|
Dec 02
2024
|
Michelle F. Link Chief of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,023
+27.53%
|
-
|
Dec 02
2024
|
Bruce Caswell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,318
-5.32%
|
$1,133,532
$74.16 P/Share
|
Dec 02
2024
|
Bruce Caswell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
31,712
+9.93%
|
-
|
Dec 02
2024
|
David Mutryn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-12.5%
|
$143,930
$74.16 P/Share
|
Dec 02
2024
|
David Mutryn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,309
+21.69%
|
-
|
Dec 02
2024
|
Theresa D Golinvaux Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
324
-6.55%
|
$23,976
$74.16 P/Share
|
Dec 02
2024
|
Theresa D Golinvaux Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
718
+12.68%
|
-
|
Dec 02
2024
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Payment of exercise price or tax liability
|
Direct |
2,592
-13.22%
|
$191,808
$74.16 P/Share
|
Dec 02
2024
|
Ilene R. Baylinson General Mgr - Health & Human |
BUY
Grant, award, or other acquisition
|
Direct |
5,172
+20.88%
|
-
|
Nov 29
2024
|
Michael J. Warren |
BUY
Open market or private purchase
|
Direct |
16
+0.39%
|
$1,168
$73.72 P/Share
|
Nov 29
2024
|
Gayathri Rajan |
BUY
Open market or private purchase
|
Direct |
73
+0.4%
|
$5,329
$73.72 P/Share
|
Oct 01
2024
|
Michelle F. Link Chief of Human Resources |
SELL
Open market or private sale
|
Direct |
1,363
-17.19%
|
$125,396
$92.56 P/Share
|
Sep 30
2024
|
Theresa D Golinvaux Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,354
-24.27%
|
$125,922
$93.16 P/Share
|
Sep 30
2024
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Payment of exercise price or tax liability
|
Direct |
4,924
-25.44%
|
$457,932
$93.16 P/Share
|
Sep 30
2024
|
David Mutryn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,205
-31.64%
|
$484,065
$93.16 P/Share
|
Sep 30
2024
|
John Thomas Martinez Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,789
-47.61%
|
$166,377
$93.16 P/Share
|
Sep 30
2024
|
Bruce Caswell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,758
-3.67%
|
$907,494
$93.16 P/Share
|
Sep 30
2024
|
Michelle F. Link Chief of Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
2,595
-24.66%
|
$241,335
$93.16 P/Share
|
Sep 03
2024
|
Michael J. Warren |
BUY
Open market or private purchase
|
Direct |
13
+0.32%
|
$1,196
$92.4 P/Share
|
Aug 30
2024
|
Gayathri Rajan |
BUY
Open market or private purchase
|
Direct |
58
+0.32%
|
$5,336
$92.39 P/Share
|
May 31
2024
|
Michael J. Warren |
BUY
Open market or private purchase
|
Direct |
14
+0.34%
|
$1,176
$84.97 P/Share
|
May 30
2024
|
Gayathri Rajan |
BUY
Open market or private purchase
|
Direct |
63
+0.35%
|
$5,292
$84.97 P/Share
|
Feb 29
2024
|
Michael J. Warren |
BUY
Open market or private purchase
|
Direct |
7
+0.17%
|
$588
$84.05 P/Share
|
Feb 29
2024
|
Gayathri Rajan |
BUY
Open market or private purchase
|
Direct |
56
+0.35%
|
$4,704
$84.06 P/Share
|
Feb 16
2024
|
David Mutryn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,000
-60.96%
|
$664,000
$83.95 P/Share
|
Dec 13
2023
|
Teresa Weipert General Mgr US Federal Segment |
SELL
Open market or private sale
|
Direct |
2,145
-39.05%
|
$182,325
$85.19 P/Share
|
Dec 12
2023
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Open market or private sale
|
Direct |
10,043
-66.76%
|
$853,655
$85.57 P/Share
|
Dec 04
2023
|
Michelle F. Link Chief of Human Resources |
SELL
Open market or private sale
|
Direct |
1,765
-26.16%
|
$150,025
$85.21 P/Share
|
Nov 30
2023
|
Gayathri Rajan |
BUY
Open market or private purchase
|
Direct |
56
+0.35%
|
$4,648
$83.37 P/Share
|
Nov 30
2023
|
Bruce Caswell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
49
-0.02%
|
$4,067
$83.49 P/Share
|
Nov 30
2023
|
Michelle F. Link Chief of Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
7
-0.1%
|
$581
$83.49 P/Share
|
Nov 30
2023
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Open market or private sale
|
Direct |
12
-0.12%
|
$996
$83.49 P/Share
|
Nov 21
2023
|
Richard A Montoni Director |
SELL
Bona fide gift
|
Indirect |
2,984
-4.09%
|
-
|
Nov 17
2023
|
Bruce Caswell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,888
-4.61%
|
$974,816
$82.31 P/Share
|
Nov 17
2023
|
Bruce Caswell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
24,611
+8.72%
|
-
|
Nov 17
2023
|
David Mutryn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.74%
|
$8,036
$82.31 P/Share
|
Nov 17
2023
|
David Mutryn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
213
+1.59%
|
-
|
Nov 17
2023
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Payment of exercise price or tax liability
|
Direct |
2,681
-21.64%
|
$219,842
$82.31 P/Share
|
Nov 17
2023
|
Ilene R. Baylinson General Mgr - Health & Human |
BUY
Grant, award, or other acquisition
|
Direct |
5,349
+30.16%
|
-
|
Nov 17
2023
|
Theresa D Golinvaux Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-6.1%
|
$14,842
$82.31 P/Share
|
Nov 17
2023
|
Theresa D Golinvaux Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+11.88%
|
-
|
Nov 17
2023
|
Michelle F. Link Chief of Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,448
-17.68%
|
$118,736
$82.31 P/Share
|
Nov 17
2023
|
Michelle F. Link Chief of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,208
+28.15%
|
-
|
Sep 29
2023
|
Ilene R. Baylinson General Mgr - Health & Human |
SELL
Open market or private sale
|
Direct |
7,073
-29.28%
|
$523,402
$74.68 P/Share
|